DK1526859T3 - Fremgangsmåde til fremstilling af et sterilt præparat af hyaluronsyre med høj molvægt - Google Patents

Fremgangsmåde til fremstilling af et sterilt præparat af hyaluronsyre med høj molvægt

Info

Publication number
DK1526859T3
DK1526859T3 DK03784399.2T DK03784399T DK1526859T3 DK 1526859 T3 DK1526859 T3 DK 1526859T3 DK 03784399 T DK03784399 T DK 03784399T DK 1526859 T3 DK1526859 T3 DK 1526859T3
Authority
DK
Denmark
Prior art keywords
preparing
molecular weight
high molecular
hyaluronic acid
acid preparation
Prior art date
Application number
DK03784399.2T
Other languages
English (en)
Inventor
Stefano Carlino
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31502852&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1526859(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medidom Lab filed Critical Medidom Lab
Application granted granted Critical
Publication of DK1526859T3 publication Critical patent/DK1526859T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
DK03784399.2T 2002-08-07 2003-08-04 Fremgangsmåde til fremstilling af et sterilt præparat af hyaluronsyre med høj molvægt DK1526859T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02405681 2002-08-07
PCT/IB2003/003524 WO2004014399A1 (en) 2002-08-07 2003-08-04 Process for preparing a sterile high molecular weight hyaluronic acid formulation

Publications (1)

Publication Number Publication Date
DK1526859T3 true DK1526859T3 (da) 2013-02-04

Family

ID=31502852

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03784399.2T DK1526859T3 (da) 2002-08-07 2003-08-04 Fremgangsmåde til fremstilling af et sterilt præparat af hyaluronsyre med høj molvægt

Country Status (21)

Country Link
US (1) US7939655B2 (da)
EP (1) EP1526859B1 (da)
JP (1) JP4597672B2 (da)
KR (1) KR101169473B1 (da)
CN (1) CN100366296C (da)
AU (1) AU2003255892B2 (da)
BR (1) BRPI0312669B8 (da)
CA (1) CA2492739C (da)
DK (1) DK1526859T3 (da)
ES (1) ES2397382T3 (da)
HK (1) HK1080715A1 (da)
HR (1) HRP20041230B1 (da)
IL (1) IL166231A (da)
MX (1) MXPA05000533A (da)
NO (1) NO334523B1 (da)
NZ (1) NZ538019A (da)
PL (1) PL217885B1 (da)
PT (1) PT1526859E (da)
SI (1) SI1526859T1 (da)
WO (1) WO2004014399A1 (da)
ZA (1) ZA200500259B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1326883C (zh) * 2005-11-04 2007-07-18 山东福瑞达生物化工有限公司 一种透明质酸钙的制备方法
CN100478360C (zh) * 2006-10-31 2009-04-15 山东福瑞达生物化工有限公司 将浓缩用于透明质酸或其盐的生产的方法
KR20100094982A (ko) 2007-11-13 2010-08-27 바이오-테크널러지 제너럴 (이스라엘) 리미티드 점탄성 바이오폴리머의 희석식 여과 멸균 방법
KR101449687B1 (ko) * 2008-03-13 2014-10-14 주식회사 바이오랜드 저분자 및 고분자 히알루론산과 유근피로부터 분리된다당체 추출물을 함유하는 노화방지용 조성물
US8283463B2 (en) 2010-02-09 2012-10-09 Bausch & Lomb Incorporated Sterile hyaluronic acid solutions
KR101379930B1 (ko) 2011-12-12 2014-04-14 가톨릭대학교 산학협력단 후발성 백내장 억제용 조성물 및 이의 제조 방법
KR20200130685A (ko) 2018-02-06 2020-11-19 리젠 랩 에스에이 가교된 히알루론산 및 prp/bmc와의 조합물
JP7457390B2 (ja) * 2018-09-20 2024-03-28 香港科技大学 点眼組成物
WO2020057606A1 (en) * 2018-09-20 2020-03-26 The Hong Kong University Of Science And Technology Eyedrop compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US5093487A (en) * 1986-01-06 1992-03-03 Mobay Corporation Low viscosity high molecular weight filter sterilizable hyaluronic acid
JP2893451B2 (ja) * 1988-08-09 1999-05-24 昭和産業株式会社 高分子量のヒアルロン酸を製造する方法
IT1251151B (it) * 1991-08-05 1995-05-04 Fidia Spa Materiale spugnoso essenzialmente costituito da acido ialuronico,o suoi derivati
IT1259090B (it) * 1992-04-17 1996-03-11 Fidia Spa Biomaterialli per protesi d'osso
JP2844296B2 (ja) * 1993-06-29 1999-01-06 正樹 佐久間 真空濃縮装置
CN1064372C (zh) * 1994-08-26 2001-04-11 顾其胜 透明质酸钠制剂的制备方法
KR19980080116A (ko) 1997-03-27 1998-11-25 히라따 다다시 히알루론산 나트륨의 정제법
CH692919A5 (fr) * 1999-01-28 2002-12-13 Trb Chemedica S A Procédé de purification de l'acide hyaluronique à poids moléculaire élevé.
US6660853B2 (en) * 2000-12-15 2003-12-09 Al Prescott Method for purifying high molecular weight hyaluronic acid
DE60117502T2 (de) 2000-12-19 2006-08-24 Seikagaku Corp. Photohärtbare Derivate von Hyaluronsäure, Verfahren zu deren Herstellung, vernetztes und photogehärtetes Derivat der Hyaluronsäure und diese enthaltendes medizinisches Material

Also Published As

Publication number Publication date
CA2492739A1 (en) 2004-02-19
ES2397382T3 (es) 2013-03-06
US20060052336A1 (en) 2006-03-09
EP1526859B1 (en) 2012-10-24
KR20050044900A (ko) 2005-05-13
BRPI0312669B1 (pt) 2015-08-11
NO334523B1 (no) 2014-03-31
CN100366296C (zh) 2008-02-06
BRPI0312669B8 (pt) 2021-05-25
HRP20041230A2 (en) 2005-06-30
SI1526859T1 (sl) 2013-01-31
NZ538019A (en) 2006-02-24
IL166231A (en) 2011-10-31
MXPA05000533A (es) 2005-04-19
NO20051181L (no) 2005-05-06
BR0312669A (pt) 2005-04-26
HK1080715A1 (en) 2006-05-04
PL217885B1 (pl) 2014-08-29
CN1674920A (zh) 2005-09-28
JP4597672B2 (ja) 2010-12-15
CA2492739C (en) 2011-05-31
PL373893A1 (en) 2005-09-19
WO2004014399A1 (en) 2004-02-19
AU2003255892A1 (en) 2004-02-25
IL166231A0 (en) 2006-01-15
JP2005536530A (ja) 2005-12-02
HRP20041230B1 (hr) 2013-02-28
ZA200500259B (en) 2005-12-28
KR101169473B1 (ko) 2012-07-30
EP1526859A1 (en) 2005-05-04
US7939655B2 (en) 2011-05-10
PT1526859E (pt) 2013-01-25
AU2003255892B2 (en) 2008-02-21

Similar Documents

Publication Publication Date Title
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
DE602004030345D1 (de) Hyaluronsäure produzierende pflanze
HK1080715A1 (en) Process for preparing a sterile high molecular weight hyaluronic acid formulation
NO20054220D0 (no) Substituerte N-arylheterocykler, fremgangsmate for fremstilling derav og deres anvendelse som legemiddel
DK1401445T3 (da) Krystallinsk anticholinergikum, fremgangsmåde til fremstilling af dette og anvendelse af dette til fremstilling af et lægemiddel
DK1482780T3 (da) Fremgangsmåde til fremstilling af et mælkeprodukt
IL172444A0 (en) Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative
FI20030490A0 (fi) Menetelmä kuitukoostumuksen valmistamiseksi
DK1383482T3 (da) Fremgangsmåde til fremstilling af en farmaceutisk lavdoseringssammensætning
DK1494647T3 (da) Fremgangsmåde til fremstilling af en steril suspension af corticosteroidpartikler til administrering ved inhalation
DK1536685T4 (da) Fremgangsmåde til fremstilling af pasta-ekstruderede sulfonamidsammensætninger
IL182505A0 (en) Purified phospholipid-non-steroidal, anti-inflammatory drug associated compositions and method for preparing and using same
FR2903100B1 (fr) Procede de preparation d'hydroquinone purifiee
DK1838683T3 (da) Fremgangsmåde til fremstilling af [1,4,5]-oxadiazepinderivater
IL218301A0 (en) Process for production of 1,2,2,2-tetrafluoro ethyl difluoro methyl ether
DK1362040T3 (da) Fremgangsmåde til fremstilling af mesylater af piperidinderivater
DK1401816T3 (da) Fremgangsmåde til fremstilling af piperidinderivatet fexofenadin
DK1682541T3 (da) Fremgangsmåde til fremstilling af tiotropiumsalte
DK1165503T3 (da) Fremgangsmåde til fremstilling af hydroxymethylthiosmörsyreesthere
ZA200705830B (en) Process for preparing high molar mass polymers
AU2003205169A8 (en) Viral vaccine production method
PT1603550E (pt) Composição farmacêutica que compreende ácido 5-metil-2-2¿- (cloro-6¿-fluoroanilino)fenilacético
DK1395587T3 (da) Fremgangsmåde til fremstilling af imipenem
ITMI20021666A1 (it) Derivati dell'acido ialuronico
IL164901A (en) Process for preparing optically active beta-aminoketones